CareFusion First Quarter Earnings on the Horizon

S&P 500 (NYSE:SPY) component CareFusion (NYSE:CFN) will unveil its latest earnings on Monday, November 7, 2011. CareFusion is a medical technology company offering clinically proven products and services designed to improve the safety and quality of healthcare.

CareFusion Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for profit of 33 cents per share, a rise of 10% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 39 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 33 cents during the last month. Analysts are projecting profit to rise by 12.1% versus last year to $1.85.

Past Earnings Performance: Last quarter, the company reported net income of 52 cents per share versus a mean estimate of profit of. The company has beaten estimates for the past three quarters.

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.

Wall St. Revenue Expectations: Analysts are projecting a decline of 7.4% in revenue from the year-earlier quarter to $840.4 million.

Analyst Ratings: seven out of 13 analysts surveyed (53.8%) have a buy rating on CareFusion.. This is below the mean analyst rating of 10 competitors, which average 67.6% buy ratings.

A Look Back: In the fourth quarter of the last fiscal year, profit rose 63.5% to $85 million (37 cents a share) from $52 million (23 cents a share) the year earlier, exceeding analyst expectations. Revenue fell 6.9% to $964 million from $1.03 billion.

Key Stats:

Revenue has fallen in the past four quarters. Revenue declined 8.9% in the third quarter of the last fiscal year from the year earlier, dropped 1.7% in second quarter of the last fiscal year from the year-ago quarter and 1.6% in the first quarter of the last fiscal year.

Competitors to Watch: Teleflex Incorporated (NYSE:TFX), Covidien plc (NYSE:COV), Thermo Fisher Scientific Inc. (NYSE:TMO), Cardinal Health, Inc. (NYSE:CAH), Masimo Corporation (NASDAQ:MASI), Angeion Corporation (NASDAQ:ANGN), NeuroMetrix, Inc. (NASDAQ:NURO), Baxter International Inc. (NYSE:BAX), C.R. Bard, Inc. (NYSE:BCR), and Stryker Corporation (NYSE:SYK).

Stock Price Performance: During August 8, 2011 to November 1, 2011, the stock price had risen $2.38 (10.7%) from $22.26 to $24.64. The stock price saw one of its best stretches over the last year between June 29, 2011 and July 7, 2011 when shares rose for six-straight days, rising 5% (+$1.35) over that span. It saw one of its worst periods between July 21, 2011 and August 2, 2011 when shares fell for nine-straight days, falling 12.8% (-$3.59) over that span. Shares are down $1.06 (-4.1%) year to date.

(Source: Xignite Financials)

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.